Detalhe da pesquisa
1.
Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
Blood
; 133(16): 1742-1752, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803990
2.
Irinotecan-induced dysarthria: A case report and review of the literature.
J Oncol Pharm Pract
; 23(3): 226-230, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911479
3.
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Cancer
; 119(14): 2555-63, 2013 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23605883
4.
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 92(3): 193-203, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394627
5.
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.
Cancer Chemother Pharmacol
; 92(2): 141-150, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368100
6.
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Cancer Res Commun
; 3(7): 1335-1349, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497337
7.
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies.
Clin Lymphoma Myeloma Leuk
; 22(7): 523-534, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260349
8.
KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer.
Cancers (Basel)
; 14(11)2022 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681762
9.
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Cancer Chemother Pharmacol
; 87(5): 689-700, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595690
10.
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
JCO Precis Oncol
; 52021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476329
11.
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
J Clin Oncol
; 38(19): 2122-2129, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369401
12.
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
J Clin Pharmacol
; 57(11): 1400-1408, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28561902
13.
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 22(6): 1356-63, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527750
14.
Metastatic Ghost Cell Odontogenic Carcinoma: Description of a Case and Search for Actionable Targets.
Rare Tumors
; 7(3): 5813, 2015 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26500725
15.
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.
J Clin Oncol
; 33(15): 1653-9, 2015 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897156
16.
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma.
J Clin Oncol
; 30(12): 1371-7, 2012 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22430274